Holen Sie sich die Stockscreener-App
36.20
3.05%
-1.14
Handel nachbörslich:
36.30
0.10
+0.28%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt HROW?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$37.34
Offen:
$37.19
24-Stunden-Volumen:
368.27K
Relative Volume:
0.73
Marktkapitalisierung:
$1.34B
Einnahmen:
$154.15M
Nettoeinkommen (Verlust:
$-33.58M
KGV:
-37.71
EPS:
-0.96
Netto-Cashflow:
$-20.74M
1W Leistung:
-7.16%
1M Leistung:
+8.32%
6M Leistung:
+38.64%
1J Leistung:
-7.86%
1-Tages-Spanne:
$36.17
$37.33
1-Wochen-Bereich:
$36.17
$39.70
52-Wochen-Spanne:
$20.85
$59.23
Harrow Inc Stock (HROW) Company Profile
Firmenname
Harrow Inc
Sektor
Telefon
615.733.4731
Adresse
1A BURTON HILLS BLVD, NASHVILLE, CA
Vergleichen Sie HROW mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HROW
Harrow Inc
|
36.20 | 1.40B | 154.15M | -33.58M | -20.74M | -0.96 |
|
ZTS
Zoetis Inc
|
153.20 | 67.75B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.29 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.84 | 43.70B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.48 | 21.51B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
380.47 | 18.31B | 2.99B | 1.21B | 1.13B | 25.06 |
Harrow Inc Stock (HROW) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-11 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-06-12 | Eingeleitet | BTIG Research | Buy |
| 2025-06-10 | Eingeleitet | William Blair | Outperform |
| 2025-02-06 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-12-04 | Bestätigt | B. Riley Securities | Buy |
| 2024-04-11 | Eingeleitet | Craig Hallum | Buy |
| 2022-09-08 | Fortgesetzt | B. Riley Securities | Buy |
| 2021-10-14 | Fortgesetzt | B. Riley Securities | Buy |
| 2021-09-24 | Eingeleitet | Aegis Capital | Buy |
| 2021-07-02 | Eingeleitet | Ladenburg Thalmann | Buy |
Alle ansehen
Harrow Inc Aktie (HROW) Neueste Nachrichten
Can you recover from losses in Harrow Inc.Weekly Profit Report & Verified Swing Trading Watchlist - Newser
Can Harrow Inc. deliver consistent dividendsWeekly Trend Summary & Weekly Watchlist for Hot Stocks - khodrobank.com
Key metrics from Harrow Inc.’s quarterly data2025 Buyback Activity & Free Long-Term Investment Growth Plans - Newser
Can volume confirm reversal in Harrow Inc.Weekly Profit Analysis & Long-Term Safe Investment Plans - Newser
What’s the outlook for Harrow Inc.’s sector2025 Price Momentum & Daily Profit Focused Stock Screening - khodrobank.com
Pattern recognition hints at Harrow Inc. upsideShare Buyback & Technical Entry and Exit Tips - Newser
When is the best time to exit Harrow Inc.Trade Analysis Report & Fast Gain Stock Trading Tips - Newser
What MACD signals say about Harrow Inc.Weekly Investment Recap & Free Growth Oriented Trading Recommendations - Newser
Candlestick signals on Harrow Inc. stock todayStop Loss & Weekly High Potential Stock Alerts - Newser
Short interest data insights for Harrow Inc.Portfolio Profit Report & Short-Term Trading Opportunity Alerts - Newser
Automated trading signals detected on Harrow Inc.Weekly Investment Report & Verified Swing Trading Watchlist - Newser
Smart tools for monitoring Harrow Inc.’s price actionJuly 2025 Short Interest & Smart Money Movement Alerts - Newser
Visual trend scoring systems applied to Harrow Inc.Market Growth Review & High Conviction Investment Ideas - Newser
Harrow, Inc. (HROW) Emerges as Eye Care Powerhouse With Biosimilars to Lucentis and Eylea - Yahoo Finance
Short Squeeze: Does Harrow Inc. stock reflect fundamentals2025 Investor Takeaways & Target Return Focused Stock Picks - خودرو بانک
Can Harrow Inc. deliver consistent EPS growthJuly 2025 PostEarnings & Fast Entry High Yield Stock Tips - khodrobank.com
Regression analysis insights on Harrow Inc. performanceQuarterly Market Review & Weekly Return Optimization Plans - Newser
Harrow jumps as Cantor initiates with Bullish view on conservative outlook - MSN
Aug Retail: Does Harrow Inc. have a competitive edgeJuly 2025 Chart Watch & Proven Capital Preservation Methods - khodrobank.com
S P Trends: Does Harrow Inc. have pricing powerEarnings Miss & Precise Entry and Exit Recommendations - khodrobank.com
Has Harrow Inc. found a price floor2025 Support & Resistance & Capital Protection Trading Alerts - Newser
The Price Is Right For Harrow, Inc. (NASDAQ:HROW) - 富途牛牛
Real time social sentiment graph for Harrow Inc.Portfolio Return Summary & Expert Approved Momentum Trade Ideas - Newser
How to build a custom watchlist for Harrow Inc.Market Growth Summary & Long-Term Safe Investment Ideas - Newser
Real time alert setup for Harrow Inc. performanceJuly 2025 Outlook & Real-Time Stock Price Movement Reports - Newser
Will Harrow Inc. bounce back from current supportQuarterly Portfolio Review & Breakout Confirmation Trade Signals - Newser
Harrow Inc. Stock Poised for Technical Comeback getLinesFromResByArray error: size == 0 - kangso.co.kr
Can Harrow Inc. Rally Enough to Break Even getLinesFromResByArray error: size == 0 - newsyoung.net
Aug Rallies: Can Harrow Inc. be the next market leaderExit Point & Real-Time Stock Movement Alerts - sundaytimes.kr
Ranking Harrow Inc. among high performing stocks via tools2025 Trading Recap & AI Driven Price Predictions - Newser
Long term hold vs stop loss in Harrow Inc.2025 Price Action Summary & Weekly Consistent Profit Watchlists - Newser
Finanzdaten der Harrow Inc-Aktie (HROW)
Umsatz
Nettogewinn
Free Cashflow
ENV
Harrow Inc-Aktie (HROW) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Opaleye Management Inc. | 10% Owner |
Jun 10 '25 |
Sale |
30.80 |
15,000 |
462,033 |
90,000 |
| Opaleye Management Inc. | 10% Owner |
Jun 09 '25 |
Sale |
30.37 |
15,204 |
461,794 |
105,000 |
| Opaleye Management Inc. | 10% Owner |
Jun 03 '25 |
Sale |
30.04 |
3,000 |
90,116 |
122,000 |
| Opaleye Management Inc. | 10% Owner |
Jun 04 '25 |
Sale |
30.02 |
1,796 |
53,907 |
120,204 |
| Opaleye Management Inc. | 10% Owner |
May 12 '25 |
Sale |
25.90 |
10,000 |
258,959 |
130,000 |
| Opaleye Management Inc. | 10% Owner |
May 13 '25 |
Sale |
26.59 |
5,000 |
132,945 |
125,000 |
| BOLL ANDREW R. | Chief Financial Officer |
Apr 03 '25 |
Option Exercise |
0.00 |
346,500 |
0 |
914,589 |
| SAHAREK JOHN P. | CEO & President, ImprimisRx |
Apr 03 '25 |
Option Exercise |
0.00 |
277,200 |
0 |
576,863 |
| BAUM MARK L | Chief Executive Officer |
Apr 03 '25 |
Option Exercise |
0.00 |
762,300 |
0 |
2,899,825 |
| Opaleye Management Inc. | 10% Owner |
Mar 18 '25 |
Sale |
30.01 |
5,000 |
150,055 |
140,000 |
3.60%
0.69%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):